FWM

Filbrandt Wealth Management Portfolio holdings

AUM $174M
1-Year Est. Return 35.59%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+35.59%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$176M
AUM Growth
+$10.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
208
New
Increased
Reduced
Closed

Top Buys

1
+$466K
2
+$356K
3
+$336K
4
NVO icon
Novo Nordisk
NVO
+$209K
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$192K

Top Sells

1
+$259K
2
+$116K
3
+$95.7K
4
IWS icon
iShares Russell Mid-Cap Value ETF
IWS
+$73.1K
5
SCHF icon
Schwab International Equity ETF
SCHF
+$64.6K

Sector Composition

1 Consumer Discretionary 1.38%
2 Technology 1.04%
3 Financials 0.96%
4 Industrials 0.84%
5 Healthcare 0.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GOOGL icon
176
Alphabet (Google) Class A
GOOGL
$3.58T
– –
-40
ADT icon
177
ADT
ADT
$5.43B
– –
-110
ANSS
178
DELISTED
Ansys
ANSS
– –
-4
BA icon
179
Boeing
BA
$164B
– –
-34
BABA icon
180
Alibaba
BABA
$291B
– –
-1
BDX icon
181
Becton Dickinson
BDX
$44B
– –
-4
CCL icon
182
Carnival Corp
CCL
$35.5B
– –
-228
CHKP icon
183
Check Point Software Technologies
CHKP
$15.9B
– –
-25
EBND icon
184
SPDR Bloomberg Emerging Markets Local Bond ETF
EBND
$2.27B
$0 ﹤0.01%
+11
ETN icon
185
Eaton
ETN
$140B
– –
-25
KN icon
186
Knowles
KN
$2.21B
– –
-100
LHX icon
187
L3Harris
LHX
$66.5B
– –
-3
NEM icon
188
Newmont
NEM
$123B
– –
-32
NOK icon
189
Nokia
NOK
$49.2B
$0 ﹤0.01%
74
SDS icon
190
ProShares UltraShort S&P500
SDS
$526M
– –
-1
STZ icon
191
Constellation Brands
STZ
$26.2B
– –
-10
TEVA icon
192
Teva Pharmaceuticals
TEVA
$35B
$0 ﹤0.01%
+20
TJX icon
193
TJX Companies
TJX
$179B
– –
-10
VCSH icon
194
Vanguard Short-Term Corporate Bond ETF
VCSH
$40.6B
– –
-100
VEU icon
195
Vanguard FTSE All-World ex-US ETF
VEU
$58.7B
– –
-238
WAB icon
196
Wabtec
WAB
$43.3B
$0 ﹤0.01%
1
XBI icon
197
State Street SPDR S&P Biotech ETF
XBI
$7.75B
– –
-5
ZTS icon
198
Zoetis
ZTS
$49.8B
– –
-10
EQC
199
DELISTED
Equity Commonwealth
EQC
– –
-10
HRTX icon
200
Heron Therapeutics
HRTX
$151M
– –
-15
5 6 7
8
9